We are pleased to share that L’Usine Digitale has featured RebrAIn for securing €3.7 million to advance our supervised AI-driven software. This innovative platform is designed to simplify the work of neurosurgeons by enhancing the precision and efficiency of Deep Brain Stimulation (DBS) procedures.
The “Waze” of neurosurgery
Our software, OptimMRI, uses cutting-edge AI algorithms to provide neurosurgeons with precise targeting information, making DBS surgeries faster, safer, and more accessible. With this funding, led by Karista and supported by Nouvelle Aquitaine Co-Investissement, we aim to expand our reach and continue our mission to improve neurosurgical outcomes globally.
The investment will support the development and commercialization of our platform, enabling more healthcare providers to benefit from our technology. We are dedicated to advancing the field of neurosurgery and enhancing patient care through innovative solutions.
For more details, read the full article in French here.
An English translation by Google is available here.
